DPP-4 Inhibitors
Sort by:
The Texas Heart Institute
Antihyperglycemic Medications for CV Risk Reduction: a Cardiologist's Perspective
FEATURING
Darren K. Mcguire
- 1,226 views
- January 18, 2024
- 10
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,253 views
- November 30, 2023
- 20
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 3
FEATURING
James Gavin Iii
- 644 views
- November 30, 2023
- 10
Scripps Health
Diabetes Treatment 2022 and Cardiovascular Risk
FEATURING
Samantha Harris
- 679 views
- June 1, 2022
- 3
Emory Diabetes Education Training Academy
Understanding Oral and Injectable Therapy Options for T2D Care
FEATURING
Sol Jacobs
- 113 views
- April 28, 2021
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Approaches to Treating Diabetes that Reduce CV Events: How Effective Are DPP-4 Inhibitors, GLP1-Receptor Agonists and SGLT-2 Inhibitors in Reducing MACE and Preventing HF Events?
FEATURING
Jia Shen
- 337 views
- February 5, 2021
- 4
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,778 views
- May 15, 2020
- 22
Emory Diabetes Education Training Academy
Antihyperglycemic Medication in Type 2 Diabetes: Overall Approach
FEATURING
Guillermo Umpierrez
- 1,219 views
- May 15, 2020
- 4
Diabetes Updates
Best of EASD 2019: CVD Perspective
FEATURING
Peter Gaede
- 167 views
- October 23, 2019
Cardiometabolic Health Congress (CMHC)
Review of Recent CVOTs Results and Clinical Implications
FEATURING
Lawrence Blonde
- 16 views
- October 22, 2019
23rd Pan Arab Conference On Diabetes
Hypoglycemic Risks of New Diabetes Drugs
FEATURING
Darin Olson
- 197 views
- May 14, 2019
- 1
23rd Pan Arab Conference On Diabetes
CVD Outcome Trials in T2DM: The Role of Newer Drugs
FEATURING
Peter Gaede
- 473 views
- May 13, 2019
- 2
23rd Pan Arab Conference On Diabetes
ADA Standards of Care: How the Guidelines can Help us in Patients with Diabetes
FEATURING
Guillermo Umpierrez
- 462 views
- May 13, 2019
Cleveland Clinic Heart, Vascular and Thoracic Institute
ESC 2018 Highlights of Late Breaking Trials
FEATURING
Steven Nissen
- 30 views
- February 5, 2019
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium
Diabetocardiology: A New Subspecialty
FEATURING
Eugene Braunwald
- 1,145 views
- January 11, 2019
- 10
3rd National Conference On Prevention Of Diabetes
CV Outcome Trials in Diabetes: The Rest of the Drugs (DPP4-I, Insulin, TZD's, SU's)
FEATURING
Darin Olson
- 548 views
- December 7, 2018
- 2
UC Davis Health Diabetes and Endocrinology Symposium
Mixing and Matching Antidiabetic Medications: What's the Best Combination?
FEATURING
John Yoon
- 1,191 views
- December 6, 2018
- 4